ARQT logo

Arcutis Biotherapeutics, Inc. (ARQT) Return On Equity

Annual ROE:

-113.76%+62.03%(+35.29%)
December 31, 2024

Summary

  • As of today, ARQT annual return on equity is -113.76%, with the most recent change of +62.03% (+35.29%) on December 31, 2024.
  • During the last 3 years, ARQT annual ROE has fallen by -41.14% (-56.65%).
  • ARQT annual ROE is now -102.78% below its all-time high of -56.10%, reached on December 31, 2019.

Performance

ARQT ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARQTprofitability metrics

Quarterly ROE:

-59.62%+15.08%(+20.19%)
June 30, 2025

Summary

  • As of today, ARQT quarterly return on equity is -59.62%, with the most recent change of +15.08% (+20.19%) on June 30, 2025.
  • Over the past year, ARQT quarterly ROE has increased by +98.82% (+62.37%).
  • ARQT quarterly ROE is now -116.72% below its all-time high of -27.51%, reached on December 31, 2018.

Performance

ARQT Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARQTprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

ARQT ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+35.3%+62.4%
3Y3 Years-56.6%+30.1%
5Y5 Years-102.8%+20.2%

ARQT ROE Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-56.6%+35.3%at high+74.3%
5Y5-Year-102.8%+35.3%-20.4%+74.3%
All-TimeAll-Time-102.8%+50.6%-116.7%+74.3%

ARQT ROE History

DateAnnualQuarterly
Jun 2025
-
-59.62%(+20.2%)
Mar 2025
-
-74.70%(+13.1%)
Dec 2024
-113.76%(+35.3%)
-86.00%(+38.1%)
Sep 2024
-
-138.99%(+12.3%)
Jun 2024
-
-158.44%(+15.4%)
Mar 2024
-
-187.25%(+19.3%)
Dec 2023
-175.79%(-43.2%)
-231.90%(-29.4%)
Sep 2023
-
-179.23%(+2.9%)
Jun 2023
-
-184.61%(-20.6%)
Mar 2023
-
-153.02%(-20.6%)
Dec 2022
-122.80%(-69.1%)
-126.90%(-12.7%)
Sep 2022
-
-112.55%(-31.9%)
Jun 2022
-
-85.30%(-29.4%)
Mar 2022
-
-65.91%(-14.8%)
DateAnnualQuarterly
Dec 2021
-72.62%(+0.4%)
-57.42%(-13.6%)
Sep 2021
-
-50.56%(-2.1%)
Jun 2021
-
-49.50%(+7.3%)
Mar 2021
-
-53.40%(+21.6%)
Dec 2020
-72.93%(-30.0%)
-68.11%(+11.2%)
Sep 2020
-
-76.68%(-2.6%)
Jun 2020
-
-74.75%(-16.9%)
Mar 2020
-
-63.95%(+22.9%)
Dec 2019
-56.10%(+26.5%)
-82.90%(+20.2%)
Sep 2019
-
-103.88%(-50.6%)
Jun 2019
-
-68.96%(-67.0%)
Mar 2019
-
-41.30%(-50.1%)
Dec 2018
-76.37%(+66.8%)
-27.51%
Dec 2017
-230.36%
-

FAQ

  • What is Arcutis Biotherapeutics, Inc. annual return on equity?
  • What is the all-time high annual ROE for Arcutis Biotherapeutics, Inc.?
  • What is Arcutis Biotherapeutics, Inc. annual ROE year-on-year change?
  • What is Arcutis Biotherapeutics, Inc. quarterly return on equity?
  • What is the all-time high quarterly ROE for Arcutis Biotherapeutics, Inc.?
  • What is Arcutis Biotherapeutics, Inc. quarterly ROE year-on-year change?

What is Arcutis Biotherapeutics, Inc. annual return on equity?

The current annual ROE of ARQT is -113.76%

What is the all-time high annual ROE for Arcutis Biotherapeutics, Inc.?

Arcutis Biotherapeutics, Inc. all-time high annual return on equity is -56.10%

What is Arcutis Biotherapeutics, Inc. annual ROE year-on-year change?

Over the past year, ARQT annual return on equity has changed by +62.03% (+35.29%)

What is Arcutis Biotherapeutics, Inc. quarterly return on equity?

The current quarterly ROE of ARQT is -59.62%

What is the all-time high quarterly ROE for Arcutis Biotherapeutics, Inc.?

Arcutis Biotherapeutics, Inc. all-time high quarterly return on equity is -27.51%

What is Arcutis Biotherapeutics, Inc. quarterly ROE year-on-year change?

Over the past year, ARQT quarterly return on equity has changed by +98.82% (+62.37%)
On this page